The burgeoning landscape of treatment for excess body fat and type 2 diabetes is currently witnessing considerable interest surrounding both retatrutide and tirzepatide. While both represent novel dual GIP and GLP-1 https://ronaldgnqs219485.eedblog.com/39135163/retatrutide-vs-tirzepatide-a-comparative-analysis